Nuclear Medicine: Page 179

CMS to loosen strings on oncology PET payments

By Brian Casey

In a move that should make PET reimbursement easier for most oncology applications, the U.S. Centers for Medicare and Medicaid Services (CMS) this week proposed removing its longstanding requirement that FDG-PET scans of patients with solid tumors be reported to a national data registry.

March 13, 2013

PETNet grows Amyvid distribution network

By AuntMinnie.com staff writers

Siemens Healthcare subsidiary PETNet Solutions has expanded its U.S. manufacturing and distribution network for Eli Lilly's PET tracer Amyvid (florbetapir) to a total of 17 metropolitan areas.

March 13, 2013

FDA clears Navidea's Lymphoseek

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration announced it has cleared radiopharmaceutical developer Navidea Biopharmaceuticals' Lymphoseek diagnostic imaging agent.

March 12, 2013

Universal Medical to sell DDD gamma cameras

By AuntMinnie.com staff writers

Universal Medical Resources has signed on to handle U.S. distribution of the CorCam dedicated cardiac gamma camera from Danish nuclear medicine technology developer DDD-Diagnostic.

March 11, 2013

'Unfair' regulatory stance on radiotracers poses threat to PET's future

By Becky McCall

VIENNA - Legal and regulatory issues surrounding the production and uses of radiotracers represent a significant threat to PET imaging, a senior luminary told ECR 2013 attendees at Sunday's professional challenges session on the legal matters related to multimodality techniques.

March 10, 2013

IBA Molecular starts Zr-89 production in U.S.

By AuntMinnie.com staff writers

Radiopharmaceutical provider IBA Molecular North America is now producing zirconium-89 (Zr-89) at its radiopharmaceutical plant in Richmond, VA.

March 10, 2013

Collaboration among specialties enhances prospects of cancer patients

By Becky McCall

VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.

March 7, 2013

FDG-PET/MRI 'comparable' to FDG-PET/CT in head/neck cancer

By Wayne Forrest

VIENNA - FDG-PET/MRI can produce diagnostic quality images "comparable" to FDG-PET/CT in patients with head and neck cancer, according to a study presented on Thursday during the opening day of ECR 2013.

March 6, 2013

Navidea posts Q4, year-end results

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has released its fourth quarter and 2012 fiscal year financial results.

March 6, 2013

Lantheus appoints new chief medical officer

By AuntMinnie.com staff writers

Diagnostic imaging agent developer Lantheus Medical Imaging said it has appointed a new chief medical officer.

March 5, 2013

Mo-99 price decreases affect Nordion's Q1 bottom line

By AuntMinnie.com staff writers

Decreases in the price of molybdenum-99 (Mo-99) adversely affected Nordion's medical isotope business in the company's first quarter of fiscal 2013.

March 5, 2013

Study shows decline in abnormal stress SPECT MPI

By Wayne Forrest

Over the past two decades, the frequency and severity of abnormal stress SPECT myocardial perfusion imaging (MPI) studies have significantly decreased, with the prevalence of abnormal SPECT exams falling from 40.9% to 8.7%, researchers reported in the March 5 issue of the Journal of the American College of Cardiology.

March 5, 2013

Previous Page

Page 179 of 440

Next Page